Also trades as: PETVW (NASDAQ) · $vol 0M
PETV OTC
PetVivo Holdings, Inc.
1W: -1.4%
1M: +0.7%
3M: +12.7%
YTD: -31.4%
1Y: +5.2%
3Y: -65.7%
5Y: -94.4%
$0.78
-0.01 (-1.14%)
Weekly Expected Move ±5.2%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider+$1.4M
Congress—
ETF Holdings—
Key Statistics
Market Cap$21.1M
52W Range0.6-1.69
Volume500
Avg Volume7,115
Beta1.28
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJohn Lai
Employees20
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-09-08
Websitepetvivo.com
5251 Edina Industrial Boulevard
Minneapolis, MN 55439
US
Minneapolis, MN 55439
US
952 405 6216
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Latest News
PetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ET
PetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ET
PetVivo Holdings, Inc. Presenting at the 3rd Annual DealFlow Discovery Conference
PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"
UPDATED: PetVivo AI, Inc. Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-90%
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| LOWENTHAL GARRY N | A-Award | 66,421 | $0.72 | 2026-05-15 |
| Lai John | A-Award | 66,421 | $0.72 | 2026-05-15 |
| Rudelius Robert Jame | A-Award | 50,000 | $0.40 | 2026-04-15 |
| A.L. Sarroff Fund, L | P-Purchase | 1,000 | $0.75 | 2026-03-23 |
| A.L. Sarroff Fund, L | P-Purchase | 23,033 | $0.68 | 2026-03-23 |